Amy K Brown

No ORCID on file · 1 paper in corpus

nonrandomized-trial 2009

A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass

Gynecologic Oncology ·doi:10.1016/j.ygyno.2008.08.031

INTRODUCTION: Patients diagnosed with epithelial ovarian cancer (EOC) have improved outcomes when cared for at centers experienced in the management of EOC. The objective of this trial was to validate a predictive model to assess the risk f…